These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7294920)

  • 1. Cell-mediated immunity in the evolution of acute and chronic HBsAg hepatitis.
    Scalise G; Mura MS; Piersimoni C
    Ann Sclavo; 1981; 23(1):92-105. PubMed ID: 7294920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular immunity in 18 cirrhotic African carriers of hepatitis B virus surface antigen (HBsAg)].
    Sankale M; Agbetra M
    Bull Soc Pathol Exot Filiales; 1977; 70(4):435-7. PubMed ID: 580921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of cellular and humoral immunity during acute and chronic HBSAG+ hepatitis].
    Scalise G; Mura MS
    Recenti Prog Med; 1978 Jul; 65(1):1-28. PubMed ID: 370933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of the migration of humanleukocytes by the surface antigen of the hepatitis B virus].
    Houle G; Gladu Y; Marleau D; Richer G
    Union Med Can; 1977 May; 106(5):677-82. PubMed ID: 867607
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunity in response to HBs antigen.
    Szkaradkiewicz A; Kiczka W
    Z Immunitatsforsch Immunobiol; 1978 Sep; 154(5):463-70. PubMed ID: 726550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell-mediated immunity to surface and core antigens of the type B hepatitis virus. I. Studies performed in the course of acute and chronic disease].
    Szymańska I
    Med Dosw Mikrobiol; 1977; 29(2):135-46. PubMed ID: 895251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of the leukocyte migration inhibition reaction to HBsAg in viral hepatitis B in children].
    Cherednichenko TV; Tamarova LD
    Vopr Okhr Materin Det; 1980 Sep; 25(9):8-12. PubMed ID: 7423898
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific cellular immunity of Australia antigen. Preliminary reports on different forms of b hepatitis].
    Erard PH; Frei PC; Peitrequin R; Hofstetter JR; Magnenat P
    Schweiz Med Wochenschr; 1974 Dec; 104(50):1882-5. PubMed ID: 4445863
    [No Abstract]   [Full Text] [Related]  

  • 9. [HBsAg in pregnancy. Effect on humoral and cellular immunity of the newborn infant].
    De Martino M; Pierro U; Genazzani A; Varone D; Vierucci A
    Minerva Pediatr; 1979 Sep; 31(17):1239-46. PubMed ID: 317128
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell mediated immunity in hepatitis B infection.
    Galbraith RM
    Minerva Gastroenterol; 1976; 22(3):233-4. PubMed ID: 1004757
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh; Asfandiiarova NS
    Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
    [No Abstract]   [Full Text] [Related]  

  • 12. [Infection and host responses. (2) Immune responses to hepatitis B virus infection and the development of disease characteristics].
    Onishi S; Ito K
    Nihon Naika Gakkai Zasshi; 1982 Oct; 71(10):1358-61. PubMed ID: 7166658
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possible mechanisms of the effect of a viral infection on the development of rheumatism].
    Gandzha IM; Giatos EP; Lysenko GI
    Ter Arkh; 1984; 56(5):105-7. PubMed ID: 6235615
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers.
    Desaules M; Frei PC; Libanska J; Wuilleret B
    J Infect Dis; 1976 Nov; 134(5):505-9. PubMed ID: 993619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of cell-mediated immunity in acute hepatitis B in the leukocyte migration inhibition test].
    Traditi F; Rossi F; Cirelli A
    Boll Soc Ital Biol Sper; 1975 Nov; 51(21):1548-51. PubMed ID: 821498
    [No Abstract]   [Full Text] [Related]  

  • 16. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison between the presence of specific circulating immune complexes and the leukocyte migration inhibition test in different clinical forms of hepatitis B].
    Krafft T; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1759-61. PubMed ID: 337469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance].
    Malacco E; Iacono G; Risso F
    Minerva Med; 1979 Feb; 70(6):479-82. PubMed ID: 431867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral immunity in viral hepatitis.
    Lee WM
    Am J Clin Pathol; 1976 May; 65(5 Suppl):866-9. PubMed ID: 85410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic significance of quantitative HBsAg determination in acute hepatitis B. Partial report of a cooperative clinical study of the DFG-focus of "virus hepatitis"].
    Gerlich W; Stamm B; Thomssen R
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():554-7. PubMed ID: 612029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.